GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease
GE醫療宣佈FDA批准Flurpiridaz F 18注射劑Pet顯影劑,用於增強冠狀動脈疾病的診斷
GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease
GE醫療宣佈FDA批准Flurpiridaz F 18注射劑Pet顯影劑,用於增強冠狀動脈疾病的診斷
譯文內容由第三人軟體翻譯。